Celebrating the 100th Feature of the Week:
Follow Lixoft on LinkedIn for more.
The More the Merrier: 3 GastroPlus Tutorials
Stream the latest tutorials in our Resource Center & YouTube with Maxime LeMerdy
Video 3 Get a quick introduction of enzymes & transporters in the gut using the ACAT™ model.
Video 4 Learn about the pKa tab and model fitting + solubility in less than 10 minutes!
Video 5 An easy to understand explanation of our algorithm to generate a new population simulation.
Comparison of pharmacokinetics and QTc effect of Quizartinib in Japanese and non-Japanese patients with Relapsed/Refractory (R/R) FLT3-ITD positive acute myeloid leukemia (AML) using population pharmacokinetic (PopPK) analyses
Quantitative systems toxicology (DILIsym) modeling of the acetaminophen (paracetamol) mode of action (MOA) pathway for hepatotoxicity supports that acetaminophen is not a carcinogenic hazard in humans
The global pandemic has highlighted, in a demonstrative way, the ‘need for speed and safety’ in model-informed drug development (MIDD).
We continue to welcome collaborations with academics, CROs, and regulatory agencies to advance the science of drug development, reduce the time and cost of research, and improve patient wellness.
Copyright © 2021 Simulations Plus, All rights reserved.
Simulations Plus Monthly News & Events
Simulations Plus, Inc.:
42505 10th Street West
Lancaster, CA 93534
Cognigen Corporation, a Simulations Plus company:
1780 Wehrle Drive, Suite 110
Buffalo, NY 14221-7000
DILIsym Services, a Simulations Plus company:
Six Davis Drive
PO Box 12317
Research Triangle Park, NC 27709
Lixoft, a Simulations Plus company
8 rue de la Renaissance Batiment D
92160 Antony, France
Telephone: +33 9 72 53 91 80